×
Customize
?
Start
Cancer Types
Quick Links
Award Programs
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Sarcoma
Kristie L. Kahl
Dana Vaughns and his colleagues rode 3,000 miles across the U.S. in support of funding research for the V Foundation.
Debu Tripathy, M.D.
Where does hope lie when it comes to improving the treatment landscape for rare cancers?
Arlene Weintraub
A new drug can break the circuit of cancer-causing effects that develop when certain genes fuse.
Kristie L. Kahl
From hereditary cancer risk among twins to study findings in squamous cell carcinoma, here’s what is making headlines in the cancer space this week.
Kristie L. Kahl
The Food and Drug Administration approved Turalio to treat patients diagnosed with a group of rare, benign tumors.
Kristie L. Kahl
The Food and Drug Administration granted a priority review to a new drug application for the accelerated approval of tazemetostat to treat metastatic or locally advanced epithelioid sarcoma not eligible for curative surgery.
Alexandra Guadagno
From today’s top performers and athletes to surprising findings about prostate cancer treatment, here’s what is making headlines in the cancer space this week.
Gina Columbus and Kristie L. Kahl
The FDA’s Oncologic Drugs Advisory Committee voted in favor of the agency approving pexidartinib to treat adult patients with symptomatic tenosynovial giant cell tumor – a rare, benign lesion that can be locally aggressive and often recurring.
Beth Fand Incollingo
The New York City chef dreamed of opening her own restaurant.
Kristie L. Kahl
The Food and Drug Administration (FDA) approved Khapzory (levoleucovorin) injection, a folate analog for three indications.